Bioengineering heart tissue for in vitro testing

Current Opinion in Biotechnology

Volumn 24, Issue 5, 2013, Pages 926-932

  Cimetta, Elisa ^a   Godier Furnémont, Amandine ^a   Vunjak Novakovic, Gordana ^a  

^a Department of Biomedical Engineering ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL SCAFFOLDS; BIOMIMETIC APPROACHES; ENVIRONMENTAL CONTROL; HIGH-THROUGHPUT SCREENING; IN-VITRO TESTING; PRE-CLINICAL TESTING; TISSUE FORMATION; UNDERLYING PRINCIPLES;

BIOMIMETICS; DIAGNOSIS; ENVIRONMENTAL MANAGEMENT; HISTOLOGY; SCAFFOLDS (BIOLOGY); STEM CELLS;

TISSUE;

CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE CELL; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; MECHANOTRANSDUCTION; MICROTECHNOLOGY; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

EID: 84884419048     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2013.07.002     Document Type: Review

References (55)

1. Atala A., Bauer S.B., Soker S., Yoo J.J., Retik A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006, 367:1241-1246.
2. Macchiarini P., Jungebluth P., Go T., Asnaghi M.A., Rees L.E., Cogan T.A., Dodson A., Martorell J., Bellini S., Parnigotto P.P., et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008, 372:2023-2030.
3. Zimmermann W.H., Didie M., Doker S., Melnychenko I., Naito H., Rogge C., Tiburcy M., Eschenhagen T. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 2006, 71:419-429.
4. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H., Gepstein L., Levenberg S. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007, 100:263-272.
5. Dahl S.L., Kypson A.P., Lawson J.H., Blum J.L., Strader J.T., Li Y., Manson R.J., Tente W.E., DiBernardo L., Hensley M.T., Carter R., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 3:68ra69.
6. Gilbert P.M., Blau H.M. Engineering a stem cell house into a home. Stem Cell Res Ther 2011, 2:3.
7. Huh D., Torisawa Y.S., Hamilton G.A., Kim H.J., Ingber D.E. Microengineered physiological biomimicry: organs-on-chips. Lab Chip 2012, 12:2156-2164. Review.
8. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
9. Olson E.N. A decade of discoveries in cardiac biology. Nat Med 2004, 10:467-474.
10. LaFlamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25:1015-1024.
11. Mercola M., Ruiz-Lozano P., Schneider M.D. Cardiac muscle regeneration: lessons from development. Genes Dev 2011, 25:299-309.
12. Mummery C., Ward-van-Oostwaard D., Doevendans P., Spijker R., Brink S.V.D., Hassink R., VanDerHeyden M., Opthof T., Pera M., DeLaRiviere A.B., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2007, 107:2733-2740.
13. Murry C.E., Keller G.M. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
14. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., Henckaerts E., Bonham K., Abbott G.W., Linden R.M., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
15. Perrimon N., Pitsouli C., Shilo B.Z. Signaling mechanisms controlling cell fate and embryonic patterning. Cold Spring Harbor Perspect Biol 2012, 4:a005975.
16. Kholodenko B.N., Hancock J.F., Kolch W. Signalling ballet in space and time. Nat Rev Mol Cell Biol 2010, 11:414-426.
17. Wong S.S., Bernstein H.S. Cardiac regeneration using human embryonic stem cells: producing cells for future therapy. Regenerative Med 2010, 5:763-775.
18. Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., Niapour M., Hotta H., Ellis J., Keller G. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8:228-240.
19. Unternaehrer J.J., Daley G.Q. Induced pluripotent stem cells for modelling human diseases. Philos Trans R Soc B: Biol Sci 2011, 366:2274-2285.
20. Braam S.R., Tertoolen L., VanDeStolpe A., Meyer T., Passier R., Mummery C.L. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 2010, 4:107-116.
21. Davis R.P., VanDenBerg C.W., Casini S., Braam S.R., Mummery C.L. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends Mol Med 2011, 17:475-484.
22. Freund J.B., Goetz J.G., Hill K.L., Vermot J. Fluid flows and forces in development: functions, features and biophysical principles. Development 2012, 139:1229-1245.
23. Mammoto T., Ingber D.E. Mechanical control of tissue and organ development. Development 2010, 137:1407-1420.
24. Voronov D.A., Taber L.A. Cardiac looping in experimental conditions: effects of extraembryonic forces. Dev Dyn 2002, 224:413-421.
25. Ruwhof C., VanDerLaarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 2000, 47:23-37.
26. Ingber D.E. Mechanobiology and diseases of mechanotransduction. Annals Med 2003, 35:1-14.
27. Wheeler-Jones C.P.D. Cell signalling in the cardiovascular system: an overview. Heart 2005, 91:1366-1374.
28. Burdick J.A., Vunjak-Novakovic G. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 2009, 15:205-219.
29. Vunjak-Novakovic G., Scadden D.T. Biomimetic platforms for human stem cell research. Cell Stem Cell 2011, 8:252-261.
30. Lutolf M.P., Gilbert P.M., Blau H.M. Designing materials to direct stem-cell fate. Nature 2009, 462:433-441.
31. Cimetta E., Figallo E., Cannizzaro C., Elvassore N., Vunjak-Novakovic G. Micro-bioreactor arrays for controlling cellular environments: design principles for human embryonic stem cell applications. Methods 2009, 47:81-89.
32. Khademhosseini A., Langer R., Borenstein J., Vacanti J.P. Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A 2006, 103:2480-2487.
33. Hung P.J., Lee P.J., Sabounchi P., Aghdam N., Lin R., Lee L.P. A novel high aspect ratio microfluidic design to provide a stable and uniform microenvironment for cell growth in a high throughput mammalian cell culture array. Lab Chip 2005, 5:44-48.
34. Squires T.M., Quake S.R. Microfluidics: fluid physics at the nanoliter scale. Rev Mod Phys 2005, 77:977-1026.
35. Di Carlo D., Wu L.Y., Lee L.P. Dynamic single cell culture array. Lab Chip 2006, 6:1445-1449.
36. Hui E.E., Bhatia S.N. Micromechanical control of cell-cell interactions. Proc Natl Acad Sci U S A 2007, 104:5722-5726.
37. Cimetta E., Sirabella D., Yeager K., Davidson K., Simon J., Moon R.T., Vunjak-Novakovic G. Microfluidic bioreactor for dynamic regulation of early mesodermal commitment in human pluripotent stem cells. Lab Chip 2013, 13:355-364.
38. Zhang Y., Sevilla A., Wan L.Q., Lemischka I.R., Vunjak-Novakovic G. Patterning pluripotency in embryonic stem cells. Stem Cells 2013, 10.1002/stem.1468.
39. Tiburcy M., Didie M., Boy O., Christalla P., Doker S., Naito H., Karikkineth B.C., El-Armouche A., Grimm M., Nose M., Eschenhagen T., et al. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ Res 2011, 109:1105-1114.
40. Du Y., Lo E., Ali S., Khademhosseini A. Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci U S A 2008, 105:9522-9527.
41. Eng G., Lee B.W., Parsa H., Chin C.D., Schneider J., Linkov G., Sia S.K., Vunjak-Novakovic G. Assembly of complex cell microenvironments using geometrically docked hydrogel shapes. Proc Natl Acad Sci U S A 2013, 110:4551-4556.
42. Duan Y., Liu Z., O'Neill J., Wan L.Q., Freytes D.O., Vunjak-Novakovic G. Hybrid gel composed of native heart matrix and collagen induces cardiac differentiation of human embryonic stem cells without supplemental growth factors. J Cardiovasc Trans Res 2011, 4:605-615.
43. Shapira-Schweitzer K., Habib M., Gepstein L., Seliktar D. A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. J Mol Cell Cardiol 2009, 46:213-224.
44. Chung C., Anderson E., Pera R.R., Pruitt B.L., Heilshorn S.C. Hydrogel crosslinking density regulates temporal contractility of human embryonic stem cell-derived cardiomyocytes in 3D cultures. Soft Matter 2012, 8:10141-10148.
45. Tulloch N.L., Muskheli V., Razumova M.V., Korte F.S., Regnier M., Hauch K.H., Pabon L., Reinecke H., Murry C.E. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 2011, 109:47-59.
46. Schaaf S., Shibamiy A.A., Mewe M., Eder A., Stohr A., Hirt M.N., Rau T., Zimmermann W.H., Conradi L., Eschenhagen T., et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS ONE 2011, 6:e26397.
47. Zhang D., Shadrin I.Y., Lam J., Xian H.Q., Snodgrass H.R., Bursac N. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013, 34:5813-5820.
48. Zhang D., Shadrin I.Y., Lam J., Xian H., Snodgrass H.R., Bursac N. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013, 34:5813-5820.
49. Tandon N., Cannizzaro C., Chao P.H., Maidhof R., Marsano A., Au H.T., Radisic M., Vunjak-Novakovic G. Electrical stimulation systems for cardiac tissue engineering. Nat Protocols 2009, 4:155-173.
50. Radisic M., Park H., Shing H., Consi T., Schoen F.J., Langer R., Freed L.E., Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci 2004, 101:18129-18134.
51. Serena E., Figallo E., Tandon N., Cannizzaro C., Gerecht S., Elvassore N., Vunjak-Novakovic G. Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp Cell Res 2009, 315:3611-3619.
52. Serena E., Cimetta E., Zatti S., Zaglia T., Zagallo M., Keller G., Elvassore N. Micro-arrayed human embryonic stem cells-derived cardiomyocytes for in vitro functional assay. PLoS One 2012, 7:e48483.
53. Hirt M.N., Sorensen N.A., Bartholdt L.M., Boeddinghaus J., Schaaf S., Eder A., Vollert I., Stohr A., Schulze T., Witten A., Stoll M., et al. Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Res Cardiol 2012, 107:307.
54. Lorenzen J.M., Martino F., Thum T. Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 2012, 107:245.
55. Nunes S.S., Miklas J.W., Liu J., Aschar-Sobbi R., Xiao Y., Zhang B., Jiang J., Massé S., Gagliardi M., Hsieh A., et al. Biowire:a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 2013, doi: 10.1038/nmeth.2524. [Epub ahead of print].